During the past decade, Zhang Yong conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhang Yong" #1 collaborator was "Shanghai Shen Kang Hospital Development Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Zhang Yong" are "Cholecystitis" (1 trials), "Gallbladder Polyps" (1 trials), "Gallbladder Stone" (1 trials) and "Sphincter of Oddi Dysfunction" (1 trials). Many other conditions were trialed in "Zhang Yong" in a lesser frequency.

Most popular intervention types in "Zhang Yong" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Danshu Capsules" (1 trials), "No intervention" (1 trials) and "Pinaverium Bromide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zhang Yong" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Zhang Yong". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Zhang Yong, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhang Yong, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".